Clinical aspects and prognostic factors of leptospirosis in adults. Retrospective study in France

Journal of Infection

Volumn 57, Issue 3, 2008, Pages 171-178

  Abgueguen, Pierre ^a   Delbos, Valerie ^a   Blanvillain, Jerome ^a   Chennebault, Jean Marie ^a   Cottin, Jane ^a   Fanello, Serge ^a   Pichard, Eric ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Clinical signs; Diagnosis; Emerging disease; Leptospirosis; Lymphopenia; Prognostic factors; Treatment; Zoonosis

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; CYCLINE; MACROLIDE; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONJUNCTIVA DISEASE; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; FEVER; FRANCE; HEADACHE; HERPES; HOSPITALIZATION; HUMAN; INTENSIVE CARE; JAUNDICE; KIDNEY INJURY; LABORATORY TEST; LEPTOSPIROSIS; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MENINGOENCEPHALITIS; MORTALITY; MYALGIA; MYOCARDITIS; PERICARDITIS; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SEROCONVERSION; SHIVERING; THROMBOCYTOPENIA; URINE CULTURE;

ADOLESCENT; ADULT; AGED; CHILD; COHORT STUDIES; FEMALE; FRANCE; HEART DISEASES; HUMANS; JAUNDICE; LEPTOSPIRA; LEPTOSPIROSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 50449105531     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.06.010     Document Type: Article

References (57)

1. World Health Organization. Leptospirosis worldwide, 1999. Wkly Epidemiol Rec 76 (2001) 109-116
2. Bharti A.R., Nally J.E., Ricaldi J.N., Matthias M.A., Diaz M.M., Lovett M.A., et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3 (2003) 757-771
3. Jansen A., Schneberg I., Frank C., Alpers K., Schneider T., and Stark K. Leptospirosis in Germany, 1962-2003. Emerging Infect Dis 11 (2005) 1048-1054
4. Pate G.E., Hogan M.C., FitzSimon N., and Mellotte G.J. A review of the epidemiology of leptospirosis in the Republic of Ireland. Ir Med J 93 (2000) 114-117
5. Vinetz J.M., Glass G.E., Flexner C.E., Mueller P., and Kaslow D.C. Sporadic urban leptospirosis. Ann Intern Med 125 (1996) 794-798
6. Tangkanakul W., Tharmaphornpil P., Plikaytis B.D., Bragg S., Poonsuksombat D., Choomkasien P., et al. Risk factors associated with leptospirosis in northeastern Thailand, 1998. Am J Trop Med Hyg 63 (2000) 204-208
7. Ko A.I., Galvao Reis M., Ribeiro Dourado C.M., Johnson Jr. W.D., and Riley L.W. Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 354 (1999) 820-825
8. Kupek E., de Sousa Santos Faversani M.C., and de Souza Philippi J.M. The relationship between rainfall and human leptospirosis in Florianopolis, Brazil, 1991-1996. Braz J Infect Dis 4 (2000) 131-134
9. Segura E., Ganoza C., Campos K., Ricaldi J.N., Torres S., Silva H., et al. Clinical spectrum of pulmonary involvement in leptospirosis in an endemic region, with quantification of leptospiral burden. Clin Infect Dis 40 (2005) 343-351
10. Johnson M.A., Smith H., Joseph P., Gilman R.H., Bautista C.T., Campos K.J., et al. Environmental exposure and leptospirosis, Peru. Emerging Infect Dis 10 (2004) 1016-1022
11. Centre National de Référence des Leptospires. Institut Pasteur (2005). http://www.pasteur.fr/recherche/Leptospira/textcnr05.html
12. Thammakumpee K., Silpapojakul K., and Borrirak B. Leptospirosis and its pulmonary complications. Respiratory 10 (2005) 656-659
13. Covic A., Goldsmith D.J., Gusbeth-Tatomir P., Seica A., and Covic M. Retrospective 5-year study in Moldova of acute renal failure due to leptospirosis: 58 cases and a review of the literature. Nephrol Dial Transplant 18 (2003) 1128-1134
14. Panicker J.N., Mammachan R., and Jayakumar R.V. Primary neuroleptospirosis. Postgrad Med J 77 (2001) 589-590
15. Dursun B., Bostan F., Artac M., Varan H.I., and Suleymanlar G. Severe pulmonary haemorrhage accompanying hepatorenal failure in fulminant leptospirosis. Int J Clin Pract 61 (2007) 164-167
16. Turhan V., Atasoyu E.M., Kucukardali Y., Polat E., Cesur T., and Cavuslu S. Leptospirosis presenting as severe rhabdomyolysis and pulmonary haemorrhage. J Infect 52 (2006) e1-e2 [Epub 2005 Jul 26]
17. Monsuez J.J., Kidouche R., Le Gueno B., and Postic D. Leptospirosis presenting as haemorrhagic fever in visitor to Africa. Lancet 349 (1997) 254-255
18. Baranton G., and Postic D. Trends in leptospirosis epidemiology in France. Sixty-six years of passive serological surveillance from 1920 to 2003. Int J Infect Dis 10 (2006) 162-170
19. Nardone A., Capek I., Baranton G., Campese C., Postic D., Vaillant V., et al. Risk factors for leptospirosis in metropolitan France: results of a national case-control study, 1999-2000. Clin Infect Dis 39 (2004) 751-753
20. Jaureguiberry S., Roussel M., Brinchault-Rabin G., Gacouin A., Le Meur A., Arvieux C., et al. Clinical presentation of leptospirosis: a retrospective study of 34 patients admitted to a single institution in metropolitan France. Clin Microbiol Infect 11 (2005) 391-394
21. Doudier B., Garcia S., Quennee V., Jarno P., and Brouqui P. Prognostic factors associated with severe leptospirosis. Clin Microbiol Infect 12 (2006) 299-300
22. Dupont H., Dupont-Perdrizet D., Perie J.L., Zehner-Hansen S., Jarrige B., and Daijardin J.B. Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis 25 (1997) 720-724
23. Pertuiset E., Fen Chong M., Duval G., and Genin R. [Clinical aspects and prognostic factors of icterohemorrhagic leptospirosis in adults. Apropos of 249 cases in La Reunion]. Rev Med Interne 9 (1988) 487-493
24. Panaphut T., Domrongkitchaiporn S., and Thinkamrop B. Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand. Int J Infect Dis 6 (2002) 52-59
25. Pappachan M.J., Mathew S., Aravindan K.P., Khader A., Bharghavan P.V., Kareem M.M., et al. Risk factors for mortality in patients with leptospirosis during an epidemic in northern Kerala. Natl Med J India 17 (2004) 240-242
26. Tantitanawat S., and Tanjatham S. Prognostic factors associated with severe leptospirosis. J Med Assoc Thai 86 (2003) 925-931
27. Daher E., Zanetta D.M., Cavalcante M.B., and Abdulkader R.C. Risk factors for death and changing patterns in leptospirosis acute renal failure. Am J Trop Med Hyg 61 (1999) 630-634
28. Esen S., Sunbul M., Leblebicioglu H., Eroglu C., and Turan D. Impact of clinical and laboratory findings on prognosis in leptospirosis. Swiss Med Wkly 134 (2004) 347-352
29. Marotto P.C., Nascimento C.M., Eluf-Neto J., Marotto M.S., Andrade L., Sztajnok J., et al. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 29 (1999) 1561-1563
30. Bovet P., Yersin C., Merien F., Davis C.E., and Perolat P. Factors associated with clinical leptospirosis: a population-based case-control study in the Seychelles (Indian Ocean). Int J Epidemiol 28 (1999) 583-590
31. Raoult D., Mailloux M., De Chanville F., and Chaudet H. [Seroepidemiologic study on leptospirosis in the Camargue region]. Bull Soc Pathol Exot Filiales 78 (1985) 439-445
32. Duval G., Michault A., Baranton G., Law-Koune J.D., Folio G., Bertil G., et al. Seroepidemiological study of human leptospirosis at Reunion Island. Rev Epidemiol Sante Publique 39 (1991) 135-141
33. Cointet F., Gilles B., Dussarat G., Le Bris H., Martini L., Brethes B., et al. Human leptospirosis in New Caledonia and dependencies. Apropos of 57 cases observed between 1 June 1983 and 31 May 1985. Bull Soc Pathol Exot Filiales 80 (1987) 28-37
34. Faine S., Adler B., Bolin C., and Perolat P. Leptospira and leptospirosis. 2nd ed. (1999), MedSci., Melbourne
35. Visith S., and Kearkiat P. Nephropathy in leptospirosis. J Postgrad Med 51 (2005) 184-188
36. Yersin C., Bovet P., Merien F., Clement J., Laille M., Van Ranst M., et al. Pulmonary haemorrhage as a predominant cause of death in leptospirosis in Seychelles. Trans R Soc Trop Med Hyg 94 (2000) 71-76
37. Martinez Garcia M.A., de Diego Damia A., Menendez Villanueva R., and Lopez Hontagas J.L. Pulmonary involvement in leptospirosis. Eur J Clin Microbiol Infect Dis 19 (2000) 471-474
38. Dussarat G.V., Cointet F., Capdevielle P., Le Bris H., and Brethes B. Cardiac manifestations in leptospirosis. Apropos of 15 cases observed in New Caledonia. Ann Cardiol Angeiol (Paris) 37 (1988) 449-453
39. Costa E., Costa Y.A., Lopes A.A., Sacramento E., and Bina J.C. Severe forms of leptospirosis: clinical, demographic and environmental aspects. Rev Soc Bras Med Trop 34 (2001) 261-267
40. Ooteman M.C., Vago A.R., and Koury M.C. Evaluation of MAT, IgM ELISA and PCR methods for the diagnosis of human leptospirosis. J Microbiol Methods 65 (2006) 247-257
41. Levett P.N. Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin Infect Dis 36 (2003) 447-452
42. Tahiliani P., Kumar M.M., Chandu D., Kumar A., Nagaraj C., and Nandi D. Gel purified LipL32: a prospective antigen for detection of leptospirosis. J Postgrad Med 51 (2005) 164-168
43. Law-Koune J.D., Duval G., Michault A., Baranton G., De Camaret P., Lemahieu J.M., et al. Human leptospirosis in Reunion Island. A 3-year epidemiological study (1985-1987). Bull Soc Pathol Exot Filiales 82 (1989) 185-191
44. Heath Jr. C.W., Alexander A.D., and Galton M.M. Leptospirosis in the United States. Analysis of 483 cases in man, 1949, 1961. N Engl J Med 73 (1965) 915-922 [concl]
45. Watt G., Padre L.P., Tuazon M.L., Calubaquib C., Santiago E., Ranoa C.P., et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1 (1988) 433-435
46. Daher E.F., and Nogueira C.B. Evaluation of penicillin therapy in patients with leptospirosis and acute renal failure. Rev Inst Med Trop Sao Paulo 42 (2000) 327-332
47. Costa E., Lopes A.A., Sacramento E., Costa Y.A., Matos E.D., Lopes M.B., et al. Penicillin at the late stage of leptospirosis: a randomized controlled trial. Rev Inst Med Trop Sao Paulo 45 (2003) 141-145
48. Guidugli F., Castro A.A., and Atallah A.N. Antibiotics for preventing leptospirosis. Cochrane Database Syst Rev (2000) CD001306
49. Bourrier P., Chennebault J.M., Achard J., Barrier J., Becq-Giraudon B., Niyongabo T., et al. [Leptospiroses : Analyse rétrospective de 99 cas observés en 10 ans dans le Centre-Ouest de la France]. Med Mal Infect 1 (1988) 4-8
50. Katz A.R., Ansdell V.E., Effler P.V., Middleton C.R., and Sasaki D.M. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998. Clin Infect Dis 3 (2001) 1834-1841
51. Jeandel P., Raoult D., Bauduceau B., Rougier Y., Mailloux M., and Auger C. Epidemiological aspects and diagnosis of 60 cases of leptospiroses in French Polynesia. Bull Soc Pathol Exot Filiales 75 (1982) 367-374
52. Ragnaud J.M., Morlat P., Buisson M., Longy-Boursier M., Monlun E., Wone C., et al. Epidemiological, clinical, biological and developmental aspects of leptospirosis: apropos of 30 cases in Aquitaine. Rev Med Interne 15 (1994) 452-459
53. Courtin J.P., Di Francia M., Du Couedic I., Poubeau P., Mahe C., Bapteste J., et al. Respiratory manifestations of leptospirosis. A retrospective study of 91 cases (1978-1984). Rev Pneumol Clin 54 (1998) 382-392
54. Artigou J.Y., Chauvet J.P., Clergue F., Drobinski G., and Grosgogeat Y. Acute myocarditis disclosing leptospirosis. Ann Cardiol Angeiol (Paris) 35 (1986) 387-389
55. Berman S.J., Tsai C.C., Holmes K., Fresh J.W., and Watten R.H. Sporadic anicteric leptospirosis in South Vietnam. A study in 150 patients. Ann Intern Med 79 (1973) 167-173
56. Merien F., Truccolo J., Rougier Y., Baranton G., and Perolat P. In vivo apoptosis of hepatocytes in guinea pigs infected with Leptospira interrogans serovar icterohaemorrhagiae. FEMS Microbiol Lett 169 (1998) 95-102
57. Plank R., and Dean D. Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humans. Microbes Infect 2 (2000) 1265-1276